By Rachel Lutz, HCPLive.com
A treatment that targets the CB2 cannabinoid receptor [example; cannabis] may be an effective treatment for rheumatoid arthritis and synovitis, according to research published in BMC Musculoskeletal Disorders.
A collaborative team of researchers from the United Kingdom investigated cannabinoid receptor isoform CB2 as a target for treatment for rheumatoid arthritis while reviewing current treatments available to patients. The researchers noted synovitis is a central component of rheumatoid arthritis while also contributing to osteoarthritis. While pain symptoms can be treated in these diseases with medications like NSAIDs or paracetamol, control of rheumatic pain is particularly difficult. Breakout medications the researchers identified were sprifermin (human recombinant FGF-18) and tanezumab (anti-NFG monoclonal antibody).